Literature DB >> 14573837

STD trends and patterns of treatment for STD by physicians in private practice in Peru.

P J Garcia1, K K Holmes.   

Abstract

OBJECTIVES: To describe trends in STD visits to physicians in private practice in Peru over a 15 year period and in the patterns of treatments used for STD.
METHODS: IMS Health conducts for pharmaceutical marketing purposes surveys of a random cluster sample of 1.63% of practising physicians in Peru, stratified by region and specialty. Physicians record details of diagnoses and treatments for all patients seen during a 7 day period every 6 months. Data collected on selected STD syndromes were retrospectively reviewed over a 15 year period.
RESULTS: The number of first visits for pelvic inflammatory disease (PID) and trichomoniasis, and total visits for genital herpes increased from 1983-5 to 1996-7; while first visits for gonorrhoea and total visits for syphilis have changed little in recent years. Treatment for gonorrhoea usually involved the use of spectinomycin or an aminoglycoside only. Treatments offered for PID were remarkably inadequate and for trichomoniasis often involved products not known to be effective for trichomoniasis or other causes of vaginal discharge.
CONCLUSIONS: This form of active surveillance provides information potentially useful to guide policies for prevention and management of STDs and HIV infections in developing countries.

Entities:  

Mesh:

Year:  2003        PMID: 14573837      PMCID: PMC1744737          DOI: 10.1136/sti.79.5.403

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  8 in total

Review 1.  Problems, solutions, and challenges in syndromic management of sexually transmitted diseases.

Authors:  G A Dallabetta; A C Gerbase; K K Holmes
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

Review 2.  Genital human papillomavirus infection. A growing concern.

Authors:  T M Becker; K M Stone; E R Alexander
Journal:  Obstet Gynecol Clin North Am       Date:  1987-06       Impact factor: 2.844

3.  Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial.

Authors:  P J Garcia; E Gotuzzo; J P Hughes; K K Holmes
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

4.  Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group.

Authors:  M J Wawer; N K Sewankambo; D Serwadda; T C Quinn; L A Paxton; N Kiwanuka; F Wabwire-Mangen; C Li; T Lutalo; F Nalugoda; C A Gaydos; L H Moulton; M O Meehan; S Ahmed; R H Gray
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

5.  Where do people go for treatment of sexually transmitted diseases?

Authors:  R M Brackbill; M R Sternberg; M Fishbein
Journal:  Fam Plann Perspect       Date:  1999 Jan-Feb

6.  Antibiotic treatment of pelvic inflammatory disease. Trends among private physicians in the United States, 1966 through 1983.

Authors:  D A Grimes; J H Blount; J Patrick; A E Washington
Journal:  JAMA       Date:  1986-12-19       Impact factor: 56.272

7.  Mucosal disruption due to use of a widely-distributed commercial vaginal product: potential to facilitate HIV transmission.

Authors:  P H Kilmarx; K Limpakarnjanarat; S Supawitkul; S Korattana; N L Young; B S Parekh; R A Respess; T D Mastro; M E St Louis
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

8.  Trends in molluscum contagiosum in the United States, 1966-1983.

Authors:  T M Becker; J H Blount; J Douglas; F N Judson
Journal:  Sex Transm Dis       Date:  1986 Apr-Jun       Impact factor: 2.830

  8 in total
  2 in total

1.  STI management and control in Latin America: where do we stand and where do we go from here?

Authors:  Patricia J Garcia; Adele S Benzaken; Enrique Galban
Journal:  Sex Transm Infect       Date:  2011-12       Impact factor: 3.519

2.  An interactive internet-based continuing education course on sexually transmitted diseases for physicians and midwives in Peru.

Authors:  Fredy A Canchihuaman; Patricia J Garcia; Stephen S Gloyd; King K Holmes
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.